Proteomic Based Drug Discovery Summit 2025
Evvnt Promotion / evvnt
Archive
11.02.2025 - 13.02.2025 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 8:30 am to 4:30 pm
Conference themes
Proteomics offers huge advantages for the discovery and pre-clinical development of small molecule drugs and their translation into robust clinical candidates. Just this year, Sanofi has dedicated $700M to Belharra Therapeutics to develop a proteomics platform and Galapagos has partnered with Bridgene Bio to combine chemoproteomics with computational tools.
This is the time to harness the power of proteomics to accelerate your drug development process and de-risk your pipeline.
Proteomics offers huge advantages for the discovery and pre-clinical development of small molecule drugs and their translation into robust clinical candidates. Just this year, Sanofi has dedicated $700M to Belharra Therapeutics to develop a proteomics platform and Galapagos has partnered with Bridgene Bio to combine chemoproteomics with computational tools.
This is the time to harness the power of proteomics to accelerate your drug development process and de-risk your pipeline.
Scientific Society
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/2674449-3?pid=4832
Speakers: Alex Campos, Senior Director - Systems Biology and Proteomics, Plexium Inc., Bekim Bajrami, Associate Scientific Director, Biogen and more.
Brochure: https://go.evvnt.com/2674449-3?pid=4832
Speakers: Alex Campos, Senior Director - Systems Biology and Proteomics, Plexium Inc., Bekim Bajrami, Associate Scientific Director, Biogen and more.
Enquiries and Registration:
https://go.evvnt.com/2674449-2?pid=4832
Ms. Lucy Rutherford
Health Services, Pharmacology and Toxicology
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
